Showing all 9 results
Each tablet contains:
Dexamethasone Sodium 0.5mg
Indicated in a wide variety of disorders amenable to glucocorticoid therapy, as well
as an adjunct in the control of cerebral edema.
Dexamethasone is used to treat conditions such as arthritis, blood/hormone/immune system disorders, allergic reactions, certain skin and eye conditions, breathing problems, certain bowel disorders, and certain cancers. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). This medication is a corticosteroid hormone (glucocorticoid). It decreases your body's natural defensive response and reduces symptoms such as swelling and allergic-type reactions.
In general, glucocorticoid dosage depends on the severity of the condition and response of the patient. Under certain circumstances, for instance in stress and changed clinical picture, extra dosage adjustments may be necessary. If no favourable response is noted within a couple of days, glucocorticoid therapy should be discontinued.
Usually, daily oral dosages of 0.5 – 10 mg are sufficient. In some patients higher dosages may be temporarily required to control the disease. Once the disease is under control, the dosage should be reduced or tapered off to the lowest suitable level under continuous monitoring and observation of the patient.
For a short dexamethasone suppression test, 1 mg dexamethasone is given at 11 pm and plasma cortisol measured the next morning. Patients who do not show a decrease in cortisol can be exposed to a longer test: 500 micrograms dexamethasone is given at 6 hourly intervals for 48 hours followed by 2 mg every 6 hours for a further 48 hours. Twenty-four hour urine collections are made before, during and at the end of the test for determination of 17-hydroxycorticosteroids.
0.01-0.1 mg/kg of body weight daily.
Dosage of glucocorticoids should be adjusted on the basis of the individual patient's response.
Or as directed by the physicianComposition: Each tablet contains:
Dexamethasone Sodium 0.5mg
Indicated in a wide variety of disorders amenable to glucocorticoid therapy, as well
as an adjunct in the control of cerebral edema.
Dexamethasone is used to treat conditions such as arthritis, blood/hormone/immune system disorders, allergic reactions, certain skin and eye conditions, breathing problems, certain bowel disorders, and certain cancers. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). This medication is a corticosteroid hormone (glucocorticoid). It decreases your body's natural defensive response and reduces symptoms such as swelling and allergic-type reactions.
In general, glucocorticoid dosage depends on the severity of the condition and response of the patient. Under certain circumstances, for instance in stress and changed clinical picture, extra dosage adjustments may be necessary. If no favourable response is noted within a couple of days, glucocorticoid therapy should be discontinued.
Usually, daily oral dosages of 0.5 – 10 mg are sufficient. In some patients higher dosages may be temporarily required to control the disease. Once the disease is under control, the dosage should be reduced or tapered off to the lowest suitable level under continuous monitoring and observation of the patient (See Section 4.4).
For a short dexamethasone suppression test, 1 mg dexamethasone is given at 11 pm and plasma cortisol measured the next morning. Patients who do not show a decrease in cortisol can be exposed to a longer test: 500 micrograms dexamethasone is given at 6 hourly intervals for 48 hours followed by 2 mg every 6 hours for a further 48 hours. Twenty-four hour urine collections are made before, during and at the end of the test for determination of 17-hydroxycorticosteroids.
0.01-0.1 mg/kg of body weight daily.
Dosage of glucocorticoids should be adjusted on the basis of the individual patient's response.
Or as directed by the physician
Ibuprofen B.P 400mg
Mb-fen is indicated for its analgesic and anti-inflammatory effects in the treatment of rheumatoid arthritis (including juvenile rheumatoid arthritis or Still's disease), ankylosing spondylitis, osteoarthritis and other non-rheumatoid (seronegative) arthropathies. In the treatment of non-articular rheumatic conditions, Mb-fen is indicated in periarticular conditions such as frozen shoulder (capsulitis), bursitis, tendonitis, tenosynovitis and low back pain; Mb-fen can also be used in soft tissue injuries such as sprains and strains. Mb-fen is also indicated for its analgesic effect in the relief of mild to moderate pain such as dysmenorrhoea, dental and post-operative pain and for symptomatic relief of headache, including migraine headache.
Adults and children over 12 years of age: The recommended dosage of Mb-fen is 1200-1800 mg daily in divided doses. Some patients can be maintained on 600-1200 mg daily. In severe or acute conditions, it can be advantageous to increase the dosage until the acute phase is brought under control, provided that the total daily dose does not exceed 2400 mg in divided doses.
The daily dosage of Mb-fen is 20 mg/kg of body weight in divided doses.
In Juvenile Rheumatoid Arthritis, up to 40 mg/kg of body weight daily in divided doses may be taken.
Elderly: The elderly are at increased risk of serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy. If renal or hepatic function is impaired, dosage should be assessed individually.
For oral administration. It is recommended that patients with sensitive stomachs take Mb-fen with food. If taken shortly after eating, the onset of action of Mb-fen may be delayed. To be taken preferably with or after food, with plenty of fluid. Mb-fen tablets should be swallowed whole and not chewed, broken, crushed or sucked on to avoid oral discomfort and throat irritation.
Each film coated tablet contains:
Montelukast sodium equivalent to Montelukast …10 mg
Montelukast Sodium is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. Montelukast Sodium is indicated for the relief of symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 6 months of age and older.
Monti should be taken once daily. For asthma, the dose should be taken in the evening. For allergic rhinitis, the time of administration may be individualized to suit patient needs. Patients with both asthma and allergic rhinitis should take only one tablet daily in the evening.Adults and Adolescents 15 Years of Age and Older with Asthma or Allergic Rhinitis: The dosage for adults and adolescents 15 years of age and older is one 10-mg tablet daily.Pediatric Patients 6 to 14 Years of Age with Asthma or Allergic Rhinitis:
The dosage for pediatric patients 6 to 14 years of age is one 5-mg chewable tablet daily.
No dosage adjustment within this age group is necessary.
Each chewable tablet contains:
Montelukast sodium equivalent to Montelukast …5 mg
Montelukast Sodium is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. Montelukast Sodium is indicated for the relief of symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 6 months of age and older.
Monti should be taken once daily. For asthma, the dose should be taken in the evening. For allergic rhinitis, the time of administration may be individualized to suit patient needs. Patients with both asthma and allergic rhinitis should take only one tablet daily in the evening.Adults and Adolescents 15 Years of Age and Older with Asthma or Allergic Rhinitis: The dosage for adults and adolescents 15 years of age and older is one 10-mg tablet daily.
Pediatric Patients 6 to 14 Years of Age with Asthma or Allergic Rhinitis:
The dosage for pediatric patients 6 to 14 years of age is one 5-mg chewable tablet daily.
No dosage adjustment within this age group is necessary.
Each film coated tablet contains:
Rosuvastatin calcium equivalent to Rosuvastatin 10mg
Hyperlipidemia and Mixed Dyslipidemia
Rosuvastatin is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate.
10mg once daily, increased if necessary after ot less than 4 weeks to 20mg once daily,Increased after further 4 weeks to 40mg only in severs hypercholesterolaemia with high cardiovascular risk and under specialist supervision, patient of angina Max.20mg per day
Each film coated tablet contains:
Rosuvastatin calcium equivalent to Rosuvastatin 20mg
Hyperlipidemia and Mixed Dyslipidemia
Rosuvastatin is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate.
10mg once daily, increased if necessary after ot less than 4 weeks to 20mg once daily,Increased after further 4 weeks to 40mg only in severs hypercholesterolaemia with high cardiovascular risk and under specialist supervision, patient of angina Max.20mg per day
Each film coated tablet contains:
Rosuvastatin calcium equivalent to Rosuvastatin 5mg
Hyperlipidemia and Mixed Dyslipidemia
Rosuvastatin is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate.
10mg once daily, increased if necessary after ot less than 4 weeks to 20mg once daily,Increased after further 4 weeks to 40mg only in severs hypercholesterolaemia with high cardiovascular risk and under specialist supervision, patient of angina Max.20mg per day
Each tablet contains:
Sulfadoxine BP…500mg, Pyrimethamine BP.. 25mg
Metafan is indicated for intermittent preventive treatment of malaria in pregnancy (IPT).
Acute falciparum malaria is potentially fatal.
3 tablets per day.
Adolescents (9- 14 years) 2 tablets per day
(4- 8 years) 1 tablet per day
(under 4 Years) ½ tablet per day
Each tablet contains:
Trypsin and chymotrypsin 50,000 units in 6:1 ratio TabletIndication:
Chymomed Tablets are primarily used for the treatment of acute inflammatory edema associated with Accidental and surgical trauma, Episiotomies, Intervertebral disc herniation, Sciatica, Thrombophlebitis, Vasectomies, Reduction in viscosity in mucus and sputum associated with bronchitis, rhinitis and sinusitis and reduction in various gastro-intestinal disorder.
For adult patients, the recommended (initial) dose of Chymomed Tablets 1 tablets 4 times a day, while the maintenance dosage is 1 tablet twice a day.